Literature DB >> 32406255

Cannabidiol for Mood Disorders: A Call for More Research.

Francesco Bartoli1,2, Bianca Bachi1, Angela Calabrese1, Federico Moretti1, Cristina Crocamo1, Giuseppe Carrà1,2,3.   

Abstract

Entities:  

Keywords:  bipolar disorder; cannabidiol; major depressive disorder; mood disorders

Year:  2020        PMID： 32406255      PMCID： PMC7918874          DOI： 10.1177/0706743720926798

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  5 in total

1.  Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis.

Authors:  Francesco Bartoli; Cristina Crocamo; Giuseppe Carrà
Journal:  Neurosci Biobehav Rev       Date:  2019-05-20       Impact factor: 8.989

2.  Trends of major depressive episode among people with cannabis use: Findings from the National Survey on Drug Use and Health 2006-2015.

Authors:  Giuseppe Carrà; Francesco Bartoli; Cristina Crocamo
Journal:  Subst Abus       Date:  2019-03-18       Impact factor: 3.716

Review 3.  Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms.

Authors:  Gabriela Pandini Silote; Ariandra Sartim; Amanda Sales; Amanda Eskelund; F S Guimarães; Gregers Wegener; Samia Joca
Journal:  J Chem Neuroanat       Date:  2019-04-27       Impact factor: 3.052

4. 

Authors:  Jairo Vinícius Pinto; Gayatri Saraf; Christian Frysch; Daniel Vigo; Kamyar Keramatian; Trisha Chakrabarty; Raymond W Lam; Márcia Kauer-Sant'Anna; Lakshmi N Yatham
Journal:  Can J Psychiatry       Date:  2019-12-13       Impact factor: 4.356

5.  Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.

Authors:  Nicola Black; Emily Stockings; Gabrielle Campbell; Lucy T Tran; Dino Zagic; Wayne D Hall; Michael Farrell; Louisa Degenhardt
Journal:  Lancet Psychiatry       Date:  2019-10-28       Impact factor: 27.083
  5 in total
  1 in total

Review 1.  Cannabidiol and substance use disorder: Dream or reality.

Authors:  Saeideh Karimi-Haghighi; Yasaman Razavi; Daniela Iezzi; Andrew F Scheyer; Olivier Manzoni; Abbas Haghparast
Journal:  Neuropharmacology       Date:  2022-01-13       Impact factor: 5.273
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.